On July 6, Nike declined 3.45% in regular trading, trading at $42.68/share, with turnover of $174 million. The stock continued to face selling pressure following its fiscal Q4 earnings release and a wave of analyst downgrades.

Multiple investment banks collectively slashed their price targets on Nike: Piper Sandler cut to $45, Telsey Advisory to $47, Barclays to $52, and Wells Fargo lowered to $40. The downgrades reflect concerns over Nike's forward guidance, which projected low-to-mid single-digit revenue declines for the first half of fiscal 2027, significantly below the prior market consensus of 0.4% growth. Greater China revenue fell 12% year-over-year in Q4, with direct-to-consumer sales still declining. While Q4 EPS of $0.72 and full-year revenue of $46.4 billion met or exceeded expectations, management commentary highlighted an increasingly challenging operating environment in global sportswear.

Additionally, 7-Eleven filed a lawsuit in Texas federal court accusing Nike of trademark infringement over the orange-green-red colorway of an Air Max 95 sneaker planned for a July 11 release, adding further uncertainty to near-term sentiment.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)